Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Pain
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Pain
    TopAbstracts in Pain 11/26/2009 - (DGNews)
    Chronic musculoskeletal pain and the occurrence of falls in an older population - (JAMA)
    Severe Joint Pain in Multiple Areas Associated With Increased Risk of Falls in Older Adults - (DGNews)
    TopAbstracts in Pain 11/19/2009 - (DGNews)
    FDA Approves Capsaicin 8% Patch for Treatment of Postherpetic Neuralgia - (DGNews)

    News archive

     Recent webcasts/CME - Pain
    • Practical Considerations in Management of Chronic Pain
    • Overview of Chronic Pain: Practical Definitions and Characteristics
    • Opioid Induced Constipation in Palliative Care : Consideration in the Care of a Unique Population
      Pain Management
      Revisiting Pain Management in Cancer Patients: Breakthrough Pain and its Treatments

      Webcasts/CME archive

       Recent cases - Pain
        A Patient with Neck Pain and Fever
        A Painful Red Eye
        A Patient with Osteoarthritis and Cardiovascular Disease Presenting with Bilateral Hip Pain: A Case Report
        Abdominal Pain Due to a Lost Guidewire: A Case Report
        Acute Abdominal Pain in a Patient Receiving Enoxaparin

        Cases archive
          




        my personal edition > pain > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Gabapentin Effective for Spinal Cord Injury in Those Able to Tolerate Side-Effects

        Clinical Journal of Pain

        04/22/2002
        By Mark Moran


        Gabapentin may be an effective treatment of pain after spinal cord injury among those able to tolerate initial and long-term side effects, say John David Putzke, PhD, and colleagues at the University of Alabama, Birmingham, Alabama, United States.

        Of 27 patients with spinal cord injury placed on an experimental trial of gabapentin and contacted six months later, 14 reported a favourable response to the agent. Favourable response was defined as a reduction of two points or more on a 0-10 pain-rating scale.

        Six of the 27 discontinued the drug because of intolerable side effects, however, the investigators report.

        A second follow-up interview 36 months after the original trial captured 11 of the 14 patients reporting a favorable response at the first interview. Of those, ten continued to report that gabapentin was an effective analgesic. There was no evidence to suggest dosing difficulties due to tolerance over the three-year period.

        Sedation, dizziness, and forgetfulness were the most common side effects, the investigators say.
        Clinical Journal of Pain 2002;18:116-121.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send